Stericycle Inc. (NASDAQ:SRCL) shares rose 0.9% during trading on Wednesday . The company traded as high as $85.93 and last traded at $85.57, with a volume of 738,035 shares trading hands. The stock had previously closed at $84.84.

A number of research analysts recently issued reports on SRCL shares. Zacks Investment Research raised Stericycle from a “hold” rating to a “buy” rating and set a $119.00 target price on the stock in a report on Thursday, July 21st. Jefferies Group reiterated a “buy” rating and issued a $140.00 price target on shares of Stericycle in a research report on Tuesday, May 17th. Imperial Capital decreased their price target on Stericycle from $100.00 to $95.00 and set an “in-line” rating for the company in a research report on Thursday, May 26th. Royal Bank Of Canada reiterated a “sell” rating on shares of Stericycle in a research report on Thursday, May 26th. Finally, Wedbush decreased their price target on Stericycle from $112.00 to $100.00 and set a “neutral” rating for the company in a research report on Monday, May 9th. Two equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and three have given a buy rating to the company. Stericycle presently has an average rating of “Hold” and an average price target of $118.15.

The stock has a market capitalization of $7.29 billion and a P/E ratio of 30.157. The firm has a 50 day moving average price of $92.68 and a 200-day moving average price of $105.46.

Stericycle (NASDAQ:SRCL) last issued its quarterly earnings results on Thursday, July 28th. The company reported $1.18 EPS for the quarter, meeting the consensus estimate of $1.18. During the same period last year, the company posted $1.14 earnings per share. The company had revenue of $891.60 million for the quarter, compared to analyst estimates of $910.29 million. The business’s revenue for the quarter was up 24.6% on a year-over-year basis. On average, analysts anticipate that Stericycle Inc. will post $4.69 earnings per share for the current fiscal year.

In related news, Director Rodney F. Dammeyer sold 10,188 shares of the stock in a transaction that occurred on Wednesday, August 17th. The stock was sold at an average price of $85.50, for a total transaction of $871,074.00. Following the completion of the transaction, the director now directly owns 10,188 shares of the company’s stock, valued at $871,074. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Mark C. Miller sold 25,000 shares of the stock in a transaction that occurred on Wednesday, June 15th. The shares were sold at an average price of $101.12, for a total value of $2,528,000.00. Following the transaction, the director now directly owns 232,786 shares of the company’s stock, valued at $23,539,320.32. The disclosure for this sale can be found here.

An institutional investor recently raised its position in Stericycle stock. US Bancorp DE increased its stake in shares of Stericycle Inc. (NASDAQ:SRCL) by 33.2% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 229,894 shares of the company’s stock after buying an additional 57,322 shares during the period. US Bancorp DE owned approximately 0.27% of Stericycle worth $27,725,000 at the end of the most recent reporting period.

Stericycle, Inc is a business-to-business services provider with a focus on regulated and compliance solutions for healthcare, retail and commercial businesses. The Company’s solutions include the collection and processing of specialized waste for disposal, the collection of personal and confidential information for secure destruction, and a range of training, consulting, recall/return, communication and compliance services.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.